Following report revealed another two TINF2 truncating mutations, p.Glu202fs/p.Leu170fs and p.Ser186fs, in altogether four cancer-prone families, where six TINF2 mutation carriers developed numerous malignancies, including three papillary thyroid carcinomas, two melanomas and three breast carcinomas. Here, TINF2 is linked to breast carcinoma.